Health ❯ Healthcare

Research

Clinical Studies Clinical Trials Clinical Research Epidemiology Medical Research Medical Studies Cancer Research Studies Meta-Analysis Systematic Reviews

5 ARTICLES

last wk.

FDA Grants Accelerated Approval for RP1 (Tudriqev) With Nivolumab in Advanced Melanoma

The agency based its decision on response‑rate results from a single‑arm IGNYTE trial with continued approval contingent on an ongoing randomized confirmatory study.

4 ARTICLES

last wk.

Automated Oxygen Titration Boosts Time in Target Saturation but Shows No Proven Clinical Benefit

3 ARTICLES

last wk.

AHA Says Up to 400 mg of Caffeine Daily Is Likely Safe for Most Healthy Adults

12 ARTICLES

2w ago

FDA Panel Rejects Deramiocel Cardiac Claim After Lancet Publishes HOPE‑3 Results

4 ARTICLES

2w ago

Study Finds Age, Sex and Education Shape Healthcare Preferences Among England’s Over‑50s

4 ARTICLES

2w ago

RWJBarnabas System Tied to 18% Drop in In-Hospital Deaths Using Epic Deterioration Index

5 ARTICLES

2w ago

Study Finds 22.8 Million More Americans Eligible for Blood Pressure Drugs

3 ARTICLES

2w ago

ProMIS Reports Blinded Six‑Month Interim Data Showing No ARIA‑E in PMN310 Phase 1b Trial

3 ARTICLES

2w ago

Family-Based Program in Primary Care Cuts Childhood Obesity in Large Trial

4 ARTICLES

2w ago

New Blood Biomarkers Differentiate Alzheimer’s Risk by Disease Stage

4 ARTICLES

3w ago

Midlife Remodeling of Human Hippocampus Linked to Microglia Loss and Genome Erosion

3 ARTICLES

3w ago

3D Genome Rearrangement Found in Alzheimer's Brain Cells, Study Shows

3 ARTICLES

3w ago

CHOP Opens David M. Einhorn Institute to Bring Caregiver-Child Relationship Science into Pediatrics

5 ARTICLES

3w ago

WHO Says Up to 45% of Dementia Risk Could Be Prevented and Adds Air Pollution to Its Guidance

25 ARTICLES

4w ago

Blood p‑tau217 Test Predicts Elevated 5‑ and 10‑Year Alzheimer’s Risk

3 ARTICLES

4w ago

State Income Linked to Lower Death Rates in Adults With Congenital Heart Disease

7 ARTICLES

4w ago

Purified THC‑CBD Drug Cuts Agitation in End‑of‑Life Dementia, Trial Shows

Research

FDA Grants Accelerated Approval for RP1 (Tudriqev) With Nivolumab in Advanced Melanoma

Automated Oxygen Titration Boosts Time in Target Saturation but Shows No Proven Clinical Benefit

AHA Says Up to 400 mg of Caffeine Daily Is Likely Safe for Most Healthy Adults

FDA Panel Rejects Deramiocel Cardiac Claim After Lancet Publishes HOPE‑3 Results

Study Finds Age, Sex and Education Shape Healthcare Preferences Among England’s Over‑50s

RWJBarnabas System Tied to 18% Drop in In-Hospital Deaths Using Epic Deterioration Index

Study Finds 22.8 Million More Americans Eligible for Blood Pressure Drugs

ProMIS Reports Blinded Six‑Month Interim Data Showing No ARIA‑E in PMN310 Phase 1b Trial

Family-Based Program in Primary Care Cuts Childhood Obesity in Large Trial

New Blood Biomarkers Differentiate Alzheimer’s Risk by Disease Stage

Never miss stories about

Research

Midlife Remodeling of Human Hippocampus Linked to Microglia Loss and Genome Erosion

3D Genome Rearrangement Found in Alzheimer's Brain Cells, Study Shows

CHOP Opens David M. Einhorn Institute to Bring Caregiver-Child Relationship Science into Pediatrics

Trial Shows Swimming Reduces Disability From Chronic Low Back Pain

WHO Updates Dementia Guidance, Says Up to 45% of Risk Is Modifiable

SORLA Protein Reduces Tau Damage and Preserves Brain in Mouse Models

WHO Says Up to 45% of Dementia Risk Could Be Prevented and Adds Air Pollution to Its Guidance

Blood p‑tau217 Test Predicts Elevated 5‑ and 10‑Year Alzheimer’s Risk

State Income Linked to Lower Death Rates in Adults With Congenital Heart Disease

Purified THC‑CBD Drug Cuts Agitation in End‑of‑Life Dementia, Trial Shows

Never miss stories about

Research